loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 2369613 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 RUFINAMIDE (1)

filter

01 EISAI LIMITED (1)

filter

01 TABLET (1)

filter

01 100MG (1)

filter

01 Canada (1)

URL Supplier Web Content
TABLET
100MG
BANZEL
Canada
2369613
30
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2369613

Looking for CTD TGA MCC DOSSIER APPLICATION 2369613 1

19

Eisai Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RUFINAMIDE, with a corresponding application number 2369613 and regulatory information .

proudly manufactured in the

Eisai Inc's BANZEL TABLET, medication with 100MG of RUFINAMIDE.

Post Enquiry
POST ENQUIRY